{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:50:23Z","timestamp":1791643823685,"version":"4.3.4"},"reference-count":6,"publisher":"Hindawi Limited","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1111\/jcpt.12397","type":"journal-article","created":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T19:19:55Z","timestamp":1463599195000},"page":"368-370","source":"Crossref","is-referenced-by-count":78,"title":["Dipeptidyl peptidase-IV inhibitors induced bullous pemphigoid: a case report and analysis of cases reported in the European pharmacovigilance database"],"prefix":"10.1155","volume":"41","author":[{"given":"M.","family":"Garc\u00eda","sequence":"first","affiliation":[{"name":"Basque Country Pharmacovigilance Unit; Galdakao-Usansolo Hospital; Galdakao Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Aranburu","sequence":"additional","affiliation":[{"name":"Mutriku Primary Health Care; Mutriku Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Palacios-Zabalza","sequence":"additional","affiliation":[{"name":"Pharmacy Service; Galdakao-Usansolo Hospital; Galdakao Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Lertxundi","sequence":"additional","affiliation":[{"name":"Pharmacy Service; Araba\u2032s Mental Health Network; Vitoria-Gasteiz Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Aguirre","sequence":"additional","affiliation":[{"name":"Basque Country Pharmacovigilance Unit; Galdakao-Usansolo Hospital; Galdakao Spain"},{"name":"Department of Pharmacology; Faculty of Medicine; University of Basque Country; Leioa Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2016,5,18]]},"reference":[{"key":"10.1111\/jcpt.12397-BIB0001|jcpt12397-cit-0001","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/bjd.13717","article-title":"Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology","volume":"172","author":"Feliciani","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1111\/jcpt.12397-BIB0002|jcpt12397-cit-0002","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.clindermatol.2013.01.006","article-title":"Bullous pemphigoid: etiology, pathogenesis, and inducing factors: facts and controversies","volume":"31","author":"Lo Schiavo","year":"2013","journal-title":"Clin Dermatol"},{"key":"10.1111\/jcpt.12397-BIB0003|jcpt12397-cit-0003","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3315\/jdcr.2014.1166","article-title":"Bullous pemphigoid associated with dipeptidyl peptidase IV inhibitors. A case report and review of literature","volume":"8","author":"Attaway","year":"2014","journal-title":"J Dermatol Case Rep"},{"key":"10.1111\/jcpt.12397-BIB0004|jcpt12397-cit-0004","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/fcp.12083","article-title":"Bullous pemphigoid induced by vildagliptin: a report of three cases","volume":"29","author":"B\u00e9n\u00e9","year":"2015","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1111\/jcpt.12397-BIB0005|jcpt12397-cit-0005","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.2337\/dc11-0804","article-title":"Dipeptidyl peptidase-4 inhibitors cause bullous pemphigoid in diabetic patients: report of two cases","volume":"34","author":"Pasmatzi","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1111\/jcpt.12397-BIB0006|jcpt12397-cit-0006","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1468-3083.2011.04062.x","article-title":"Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin","volume":"26","author":"Skandalis","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12397","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12397","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12397\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:01:35Z","timestamp":1671818495000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,18]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12397","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5,18]]}}}